Asthma: Causes, Symptoms, Diagnosis, Treatment and Complications
Verified
Added on 2023/06/04
|3
|694
|62
AI Summary
This article provides an overview of asthma, including its causes, symptoms, diagnosis, treatment, and complications. It also covers prevention and management of asthma attacks. Risk factors, influences, and course of the disease are discussed. The article includes references to recent research studies.
Contribute Materials
Your contribution can guide someone’s learning journey. Share your
documents today.
Asthma attacks Aetiology Triggering factor causes inflammation of airways This leads to activation of T lymphocytes and mast cell Activated, this further leads to bronchial hyper responsiveness [2] Pathogenesis Genetic or environment factorstimulation of B cells to produce IgEactivation of helper t cellsallergens crosslink IgEs on mast cellsrelease of histamines and other inflammatory mediators Vasodilation, increased mucus secretion, and soft muscle contractionairway obstruction Acute severe asthma [3] Clinical features Breath issues Unable to speak the full sentence in a single breath Respiratory rate is less than25 BPM [3] Diagnosis Chest X-rays Arterial blood gas (ABG) analysis Peak expiratory flow or PEF [4] Course of disease With treatment:the gas exchange is controlled, symptoms will be resolved Without treatment:the asthma symptoms may become worsen, may leads top death [4] Complications Tachycardia and hypokalaemia lack of sleep, nausea, skin changes headache, sinus pain, and cough p[4] Disease prognosis Deaths caused by acute severe asthma was increased by forty per cent between 1993 to 1995 Complication like congestive heart failure may be caused due to delayed treatment [6] Primary prevention Oxygen administration Use of Corticosteroids Immediately ventilation support [2] Treatment Secondary prevention Medicine (e.g. Nebulised Salbutamol) Rehabilitation Advice the patient related to exercise Eating healthy diet Patient education [5] Medical Mechanical ventilation) Nursing acute phase Assessment of vital signs Avoid allergens Maintaining healthy environment Recording any complication [2] Results in Causes Previous asthma attack Illegal drug use Exercise Allergens [1] Acute severe Asthma A c u t e s e v e r e a s t h m a i s c o n s i d e r e d a s t h e a s t h m a ti c a tt a c k t h a t h a s n o t b e e n i m p r o v e d b y u s i n g p r e v i o u s t r e a t m e n t m e t h o d s [ 1 ] Risk factors Diagnosed by Leads to immediate needs for Influences Prevent occurrence of
Secure Best Marks with AI Grader
Need help grading? Try our AI Grader for instant feedback on your assignments.
References 1.Ducharme, F. M., Zemek, R., Chauhan, B. F., Gravel, J., Chalut, D., Poonai, N., & research group of the Pediatric, doorway (2016). Factors associated with failure of emergency department management in children with acute moderate or severe asthma: a prospective, multicentre, cohort study.The Lancet Respiratory Medicine,4(12), 990-998. 2.Ducharme, F. M., Zemek, R., Chauhan, B., Gravel, J., Chalut, D., Poonai, N., & Krajinovic, M. (2015). B21 TRANSLATIONAL ASTHMA RESEARCH: Determinants Of Oral Corticosteroid Responsiveness In Wheezing Asthmatic Youth (doorway): A Multicentre Prospective Cohort Study Of Children With Acute Moderate Or Severe Asthma Exacerbations.American Journal of Respiratory and Critical Care Medicine,191, 1. 3.Castillo, J. R., Peters, S. P., & Busse, W. W. (2017). Asthma exacerbations: pathogenesis, prevention, and treatment.The Journal of Allergy and Clinical Immunology: In Practice,5(4), 918-927. 4.Sandrock, C. E., & Norris, A. (2015). Infection in severe asthma exacerbations and critical asthma syndrome.Clinical reviews in allergy & immunology,48(1), 104-113. 5.Zorowitz, R. D. (2016). ICU–Acquired Weakness: A Rehabilitation Perspective of Diagnosis, Treatment, and Functional Management.Chest,150(4), 966-971.
6.FitzGerald, J. M., Bleecker, E. R., Nair, P., Korn, S., Ohta, K., Lommatzsch, M., ... & Gilmartin, G. (2016). Benralizumab, an anti- interleukin-5 receptor α monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial.The Lancet,388(10056), 2128-2141.